2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Neoplasm of Lung: new trials by email Literature Review of Neoplasm of Lung trials Research Report on Neoplasm of Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of NanoPac Intratumoral Injection in Lung Cancer NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension - Lung Cancer, Nonsmall Cell, Lung Cancer | Phase 2 | Completed | NanOlogy, LLC | 18 | 2021-04-14 | 2025-05-23 |
| CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab APX005M, Nivolumab - Cancer, Non Small Cell Lung Cancer Metastatic | Phase 1 / Phase 2 | Completed | Apexigen America, Inc. | 140 | 2017-07-10 | 2023-12-26 |
Lung Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Melanoma (1) · Neoplasms (1) · Small Cell Lung Carcinoma (1)
Lung Diseases (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1) · Nevi and Melanomas (1) · Skin Diseases (1)
Nivolumab (1) · Paclitaxel (1) · Powders (1) · Suspensions (1) · sotigalimab (1)
Apexigen America, Inc. (1) · NanOlogy, LLC (1)
United States (2) · Spain (1)